<DOC>
	<DOCNO>NCT02211872</DOCNO>
	<brief_summary>The primary objective study determine maximum tolerate dose ( MTD ) BI 2536 BS patient advance solid tumour . Secondary objective evaluation safety , efficacy , pharmacokinetics BI 2536 BS</brief_summary>
	<brief_title>BI 2536 BS Patients With Advanced Solid Tumours Repeated Administration Patients With Clinical Benefit</brief_title>
	<detailed_description />
	<criteria>Patients confirm diagnosis advance , non resectable / metastatic solid tumour , fail conventional treatment , therapy proven efficacy exists , amenable establish form treatment Evaluable tumour deposit Age 18 year old Life expectancy least 6 month Written inform consent consistent international conference harmonization ( ICH ) good clinical practice ( GCP ) local legislation Eastern Cooperative Oncology Group ( ECOG , R010787 ) performance score ≤ 2 And full recovery therapyrelated toxicity previous chemo , hormone , immuno , radiotherapies Serious illness concomitant nononcological disease consider investigator incompatible trial protocol Pregnancy breastfeed Active infectious disease Known brain metastasis Second malignancy require therapy Absolute neutrophil count le 1500/mm3 Platelet count less 100 000/mm3 Bilirubin great 1.5 mg/dL ( &gt; 26 μmol/L , international system unit ( SI ) equivalent ) Aspartate amino transferase ( AST ) / alanine amino transferase ( ALT ) great 2.5 time upper limit normal ( related liver metastasis great five time upper limit normal ) Serum creatinine great 1.5 mg/dL ( &gt; 132 μmol/L , SI unit equivalent ) Sexually active woman men unwilling use medically acceptable method contraception Treatment investigational drug participation another clinical trial within past four week start therapy concomitantly trial ( except present trial drug ) Chemo , radio immunotherapy within past four week start therapy concomitantly trial Patients unable comply trial protocol Or active alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>